CD4 and cancer: Critically, cell culture studies demonstrated that DCs acquired preformed p‐MHCII complexes from dying cancer cells through cell‐to‐cell contacts and membrane transfer, which was conducive to the activation of CD4+ T cells (Dolan et al, 2006a).